TipRanks
TipRanksTop Financial ExpertsInsidersMartin Madaus

Martin Madaus Insider Profile

11 Followers
Martin Madaus, Director at Haemonetics, holds 44.06K shares in Azenta (Ticker: AZTA), holds 2.54K shares in Haemonetics (Ticker: HAE), holds 8.39K shares in Repligen (Ticker: RGEN).
See the Hottest Stocks Based on Insider Trading >
tipranks
Martin Madaus

Martin Madaus
Haemonetics (HAE)
Director

Ranked #11,656 out of 109,030 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

+30.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$7M
39.98%
21.22%
20.93%
12.79%
5.08% Others
A breakdown of Martin Madaus's holdings
See the Top Stocks by Insiders

Insider Roles

Mettler-Toledo
(MTD)
Director
Repligen
(RGEN)
Director
Azenta
(AZTA)
Interim CEO
Quanterix
(QTRX)
Director
+2 other positions
Roles that Martin Madaus holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Quanterix
(QTRX)
Rating:Informative Buy
Date:Aug 10, 2022 - Aug 10, 2023
Return:+182.40%
The most profitable trade made by Martin Madaus
See the Latest Stocks Traded by Insiders

Martin Madaus's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HAE
Haemonetics
Jul 28, 2026
Director
Uninformative Buy
―
$275.12K
MTD
Mettler-Toledo
Nov 20, 2014
Director
Informative Sell
1.34M
$2.80M
QTRX
Quanterix
Jan 06, 2025
Director
Uninformative Buy
―
$895.03K
LAB
Standard BioTools
Oct 20, 2023
Director
Uninformative Buy
4.00K
$80.06K
RGEN
Repligen
May 18, 2026
Director
Uninformative Buy
―
$1.48M
AZTA
Azenta
Sep 16, 2026
Interim CEO
Uninformative Buy
―
$1.46M
HOLX
Hologic
Mar 02, 2026
―
Uninformative Buy
―
$824.02K
COV
Covidien
Feb 24, 2014
―
Uninformative Buy
855.36
―
List of latest transactions for each holding click on a transaction to see Martin Madaus's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Martin Madaus insider profile FAQ

What is the percentage of profitable transactions made by Martin Madaus?
The percentage of profitable transactions made by Martin Madaus is 67%.
    What is the average return per transaction made by Martin Madaus?
    The average return per transaction made by Martin Madaus is 30.30%.
      What stocks does Martin Madaus hold?
      Martin Madaus holds: HAE, MTD, QTRX, LAB, RGEN, AZTA, HOLX, COV stocks.
        What was Martin Madaus’s latest transaction?
        Martin Madaus latest transaction was an Uninformative Buy of ―.
          What was Martin Madaus's most profitable transaction?
          Martin Madaus’s most profitable transaction was an Informative Buy of QTRX stock on August 10, 2022. The return on the trade was 182.40%.
            What is Martin Madaus's role in Haemonetics?
            Martin Madaus's role in Haemonetics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.